|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
Dr David Lovell Dr Lovell was appointed as a member in April 2006. He is Reader in Medical Statistics at the Postgraduate Medical School at the University of Surrey. Previously he was Associated Director and Head of Biostatistics support to Clinical Pharmacogenomics at Pfizer Global Research and Development (PGRD) in Sandwich, Kent providing data management and statistical support to pharmacogenetics and genomics. His PhD was from the Department of Human Genetics and Biometry at University College in London in 1980. He joined Pfizer in 1999 as the Biometrics Head of Clinical Pharmacogenetics. Before joining Pfizer, David was Head of the Science Division at BIBRA International, Carshalton, which included Molecular Biology, Genetic Toxicology, Biostatistics and Computer Services. At BIBRA David managed the statistical and computing group providing specialised statistical support to BIBRA's Clinical Unit and contract research work. He conducted and managed research programmes on genetics, statistics and quantitative risk assessment for the EU and UK Government Departments. His research interests at BIBRA were in the use of mathematical and statistical methods together with genetics models in the understanding of toxicological mechanisms and risk assessment problems. David had previously been a Senior Research Officer with the MRC Experimental Embryology and Teratology Unit, a visiting Postdoctoral Fellow at the NIEHS in North Carolina, USA, a Geneticist at the MRC Laboratories, Carshalton and a Research Assistant in Cytogenetics at Birmingham University. He has acted as a consultant to a number of organisations, has considerable experience of working with Regulatory Authorities, has many publications related to his work and has wide experience of making presentations to a wide range of audiences.
Declaration of interests
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
You
are here: 